nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—MAPK15—brainstem—Creutzfeldt-Jakob disease	0.0279	0.0324	CbGeAlD
Sorafenib—FLT3—blood plasma—Creutzfeldt-Jakob disease	0.0206	0.0239	CbGeAlD
Sorafenib—CDKL2—central nervous system—Creutzfeldt-Jakob disease	0.0156	0.0181	CbGeAlD
Sorafenib—RALBP1—blood plasma—Creutzfeldt-Jakob disease	0.0153	0.0178	CbGeAlD
Sorafenib—FLT1—blood plasma—Creutzfeldt-Jakob disease	0.0146	0.0169	CbGeAlD
Sorafenib—MAPK15—central nervous system—Creutzfeldt-Jakob disease	0.0141	0.0163	CbGeAlD
Sorafenib—STK10—blood plasma—Creutzfeldt-Jakob disease	0.0138	0.016	CbGeAlD
Sorafenib—CDKL3—brain—Creutzfeldt-Jakob disease	0.0136	0.0157	CbGeAlD
Sorafenib—UGT1A1—blood plasma—Creutzfeldt-Jakob disease	0.013	0.0151	CbGeAlD
Sorafenib—FLT1—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.0128	0.0928	CbGpPWpGaD
Sorafenib—CDKL2—brain—Creutzfeldt-Jakob disease	0.0124	0.0144	CbGeAlD
Sorafenib—KDR—blood plasma—Creutzfeldt-Jakob disease	0.0123	0.0143	CbGeAlD
Sorafenib—CSF1R—blood plasma—Creutzfeldt-Jakob disease	0.012	0.0139	CbGeAlD
Sorafenib—MAPK15—brain—Creutzfeldt-Jakob disease	0.0112	0.013	CbGeAlD
Sorafenib—CDK7—lymphoid tissue—Creutzfeldt-Jakob disease	0.0112	0.0129	CbGeAlD
Sorafenib—KIT—blood plasma—Creutzfeldt-Jakob disease	0.0109	0.0127	CbGeAlD
Sorafenib—ZAK—lymphoid tissue—Creutzfeldt-Jakob disease	0.00964	0.0112	CbGeAlD
Sorafenib—ABCC4—blood plasma—Creutzfeldt-Jakob disease	0.00848	0.00984	CbGeAlD
Sorafenib—MAPK11—central nervous system—Creutzfeldt-Jakob disease	0.00834	0.00968	CbGeAlD
Sorafenib—RAF1—brainstem—Creutzfeldt-Jakob disease	0.00821	0.00953	CbGeAlD
Sorafenib—CDK7—central nervous system—Creutzfeldt-Jakob disease	0.00821	0.00952	CbGeAlD
Sorafenib—MAPK11—cerebellum—Creutzfeldt-Jakob disease	0.00815	0.00946	CbGeAlD
Sorafenib—AURKC—central nervous system—Creutzfeldt-Jakob disease	0.00808	0.00937	CbGeAlD
Sorafenib—FLT3—lymphoid tissue—Creutzfeldt-Jakob disease	0.00802	0.00931	CbGeAlD
Sorafenib—CDK7—cerebellum—Creutzfeldt-Jakob disease	0.00802	0.00931	CbGeAlD
Sorafenib—TAOK2—cerebellum—Creutzfeldt-Jakob disease	0.00796	0.00923	CbGeAlD
Sorafenib—HIPK4—brain—Creutzfeldt-Jakob disease	0.00751	0.00872	CbGeAlD
Sorafenib—EPHA6—central nervous system—Creutzfeldt-Jakob disease	0.00748	0.00868	CbGeAlD
Sorafenib—FLT4—lymphoid tissue—Creutzfeldt-Jakob disease	0.00729	0.00846	CbGeAlD
Sorafenib—ZAK—central nervous system—Creutzfeldt-Jakob disease	0.00709	0.00823	CbGeAlD
Sorafenib—CYP2C19—blood plasma—Creutzfeldt-Jakob disease	0.00705	0.00818	CbGeAlD
Sorafenib—MAP2K5—brainstem—Creutzfeldt-Jakob disease	0.00698	0.0081	CbGeAlD
Sorafenib—ZAK—cerebellum—Creutzfeldt-Jakob disease	0.00693	0.00804	CbGeAlD
Sorafenib—MAP3K19—central nervous system—Creutzfeldt-Jakob disease	0.0068	0.00789	CbGeAlD
Sorafenib—HIPK3—cerebellum—Creutzfeldt-Jakob disease	0.00678	0.00787	CbGeAlD
Sorafenib—MAPK11—brain—Creutzfeldt-Jakob disease	0.00662	0.00768	CbGeAlD
Sorafenib—MKNK2—lymphoid tissue—Creutzfeldt-Jakob disease	0.0066	0.00765	CbGeAlD
Sorafenib—FGFR1—spinal cord—Creutzfeldt-Jakob disease	0.00652	0.00756	CbGeAlD
Sorafenib—CDK7—brain—Creutzfeldt-Jakob disease	0.00651	0.00756	CbGeAlD
Sorafenib—MKNK1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00651	0.00756	CbGeAlD
Sorafenib—TIE1—central nervous system—Creutzfeldt-Jakob disease	0.00649	0.00753	CbGeAlD
Sorafenib—TAOK2—brain—Creutzfeldt-Jakob disease	0.00646	0.0075	CbGeAlD
Sorafenib—RET—lymphoid tissue—Creutzfeldt-Jakob disease	0.00643	0.00746	CbGeAlD
Sorafenib—AURKC—brain—Creutzfeldt-Jakob disease	0.00641	0.00744	CbGeAlD
Sorafenib—TIE1—cerebellum—Creutzfeldt-Jakob disease	0.00634	0.00736	CbGeAlD
Sorafenib—FGFR1—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.00627	0.0454	CbGpPWpGaD
Sorafenib—KIT—brainstem—Creutzfeldt-Jakob disease	0.00619	0.00718	CbGeAlD
Sorafenib—MAP3K7—spinal cord—Creutzfeldt-Jakob disease	0.00617	0.00716	CbGeAlD
Sorafenib—CYP2C8—blood plasma—Creutzfeldt-Jakob disease	0.00616	0.00714	CbGeAlD
Sorafenib—BRAF—cerebellum—Creutzfeldt-Jakob disease	0.00608	0.00705	CbGeAlD
Sorafenib—MKNK2—spinal cord—Creutzfeldt-Jakob disease	0.00598	0.00694	CbGeAlD
Sorafenib—EPHA6—brain—Creutzfeldt-Jakob disease	0.00594	0.00689	CbGeAlD
Sorafenib—MKNK1—spinal cord—Creutzfeldt-Jakob disease	0.00591	0.00685	CbGeAlD
Sorafenib—RET—spinal cord—Creutzfeldt-Jakob disease	0.00583	0.00677	CbGeAlD
Sorafenib—EPHX2—cerebellum—Creutzfeldt-Jakob disease	0.00581	0.00674	CbGeAlD
Sorafenib—FLT3—cerebellum—Creutzfeldt-Jakob disease	0.00577	0.00669	CbGeAlD
Sorafenib—CYP1A2—blood plasma—Creutzfeldt-Jakob disease	0.00576	0.00668	CbGeAlD
Sorafenib—FLT1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00567	0.00657	CbGeAlD
Sorafenib—RAF1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00563	0.00654	CbGeAlD
Sorafenib—ZAK—brain—Creutzfeldt-Jakob disease	0.00563	0.00653	CbGeAlD
Sorafenib—RAF1—GP1b-IX-V activation signalling—YWHAZ—Creutzfeldt-Jakob disease	0.00562	0.0407	CbGpPWpGaD
Sorafenib—CYP3A5—blood plasma—Creutzfeldt-Jakob disease	0.00556	0.00645	CbGeAlD
Sorafenib—CYP2B6—blood plasma—Creutzfeldt-Jakob disease	0.00552	0.00641	CbGeAlD
Sorafenib—HIPK3—brain—Creutzfeldt-Jakob disease	0.00551	0.00639	CbGeAlD
Sorafenib—CYP2C9—blood plasma—Creutzfeldt-Jakob disease	0.00547	0.00634	CbGeAlD
Sorafenib—RALBP1—spinal cord—Creutzfeldt-Jakob disease	0.0054	0.00627	CbGeAlD
Sorafenib—MAP3K19—brain—Creutzfeldt-Jakob disease	0.0054	0.00626	CbGeAlD
Sorafenib—MAPK11—KSRP destabilizes mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.00537	0.0388	CbGpPWpGaD
Sorafenib—STK10—lymphoid tissue—Creutzfeldt-Jakob disease	0.00536	0.00622	CbGeAlD
Sorafenib—PDGFRA—lymphoid tissue—Creutzfeldt-Jakob disease	0.00531	0.00616	CbGeAlD
Sorafenib—FGFR1—cerebellum—Creutzfeldt-Jakob disease	0.00517	0.006	CbGeAlD
Sorafenib—TIE1—brain—Creutzfeldt-Jakob disease	0.00515	0.00598	CbGeAlD
Sorafenib—FLT1—spinal cord—Creutzfeldt-Jakob disease	0.00514	0.00596	CbGeAlD
Sorafenib—RAF1—spinal cord—Creutzfeldt-Jakob disease	0.00511	0.00593	CbGeAlD
Sorafenib—HTR2C—brainstem—Creutzfeldt-Jakob disease	0.0051	0.00591	CbGeAlD
Sorafenib—EPHB6—spinal cord—Creutzfeldt-Jakob disease	0.00508	0.00589	CbGeAlD
Sorafenib—BRAF—brain—Creutzfeldt-Jakob disease	0.00494	0.00573	CbGeAlD
Sorafenib—MAP3K7—cerebellum—Creutzfeldt-Jakob disease	0.00489	0.00568	CbGeAlD
Sorafenib—MKNK2—central nervous system—Creutzfeldt-Jakob disease	0.00485	0.00563	CbGeAlD
Sorafenib—PDGFRA—spinal cord—Creutzfeldt-Jakob disease	0.00481	0.00559	CbGeAlD
Sorafenib—MKNK1—central nervous system—Creutzfeldt-Jakob disease	0.00479	0.00556	CbGeAlD
Sorafenib—KDR—lymphoid tissue—Creutzfeldt-Jakob disease	0.00479	0.00556	CbGeAlD
Sorafenib—MKNK2—cerebellum—Creutzfeldt-Jakob disease	0.00474	0.0055	CbGeAlD
Sorafenib—RET—central nervous system—Creutzfeldt-Jakob disease	0.00473	0.00549	CbGeAlD
Sorafenib—EPHX2—brain—Creutzfeldt-Jakob disease	0.00472	0.00547	CbGeAlD
Sorafenib—MKNK1—cerebellum—Creutzfeldt-Jakob disease	0.00468	0.00543	CbGeAlD
Sorafenib—CSF1R—lymphoid tissue—Creutzfeldt-Jakob disease	0.00467	0.00542	CbGeAlD
Sorafenib—RET—cerebellum—Creutzfeldt-Jakob disease	0.00463	0.00537	CbGeAlD
Sorafenib—MUSK—Extracellular matrix organization—CTSD—Creutzfeldt-Jakob disease	0.00461	0.0334	CbGpPWpGaD
Sorafenib—MAPK11—p38 signaling mediated by MAPKAP kinases—YWHAZ—Creutzfeldt-Jakob disease	0.00453	0.0328	CbGpPWpGaD
Sorafenib—RALBP1—central nervous system—Creutzfeldt-Jakob disease	0.00438	0.00508	CbGeAlD
Sorafenib—KDR—spinal cord—Creutzfeldt-Jakob disease	0.00434	0.00504	CbGeAlD
Sorafenib—MAP2K5—spinal cord—Creutzfeldt-Jakob disease	0.00434	0.00504	CbGeAlD
Sorafenib—RALBP1—cerebellum—Creutzfeldt-Jakob disease	0.00428	0.00497	CbGeAlD
Sorafenib—FLT4—brain—Creutzfeldt-Jakob disease	0.00426	0.00494	CbGeAlD
Sorafenib—KIT—lymphoid tissue—Creutzfeldt-Jakob disease	0.00424	0.00493	CbGeAlD
Sorafenib—CSF1R—spinal cord—Creutzfeldt-Jakob disease	0.00424	0.00492	CbGeAlD
Sorafenib—FGFR1—brain—Creutzfeldt-Jakob disease	0.0042	0.00487	CbGeAlD
Sorafenib—CYP3A4—blood plasma—Creutzfeldt-Jakob disease	0.00417	0.00484	CbGeAlD
Sorafenib—FLT1—central nervous system—Creutzfeldt-Jakob disease	0.00417	0.00484	CbGeAlD
Sorafenib—PDGFRB—lymphoid tissue—Creutzfeldt-Jakob disease	0.00415	0.00481	CbGeAlD
Sorafenib—RAF1—central nervous system—Creutzfeldt-Jakob disease	0.00414	0.00481	CbGeAlD
Sorafenib—EPHB6—central nervous system—Creutzfeldt-Jakob disease	0.00412	0.00478	CbGeAlD
Sorafenib—CYP2D6—blood plasma—Creutzfeldt-Jakob disease	0.0041	0.00476	CbGeAlD
Sorafenib—FLT1—cerebellum—Creutzfeldt-Jakob disease	0.00407	0.00473	CbGeAlD
Sorafenib—RAF1—cerebellum—Creutzfeldt-Jakob disease	0.00405	0.0047	CbGeAlD
Sorafenib—EPHB6—cerebellum—Creutzfeldt-Jakob disease	0.00403	0.00467	CbGeAlD
Sorafenib—MAP3K7—brain—Creutzfeldt-Jakob disease	0.00397	0.00461	CbGeAlD
Sorafenib—STK10—central nervous system—Creutzfeldt-Jakob disease	0.00395	0.00458	CbGeAlD
Sorafenib—PDGFRA—central nervous system—Creutzfeldt-Jakob disease	0.00391	0.00453	CbGeAlD
Sorafenib—RAF1—Rap1 signalling—YWHAZ—Creutzfeldt-Jakob disease	0.00386	0.0279	CbGpPWpGaD
Sorafenib—STK10—cerebellum—Creutzfeldt-Jakob disease	0.00386	0.00447	CbGeAlD
Sorafenib—MKNK2—brain—Creutzfeldt-Jakob disease	0.00385	0.00447	CbGeAlD
Sorafenib—KIT—spinal cord—Creutzfeldt-Jakob disease	0.00385	0.00447	CbGeAlD
Sorafenib—PDGFRA—cerebellum—Creutzfeldt-Jakob disease	0.00382	0.00443	CbGeAlD
Sorafenib—MKNK1—brain—Creutzfeldt-Jakob disease	0.0038	0.00441	CbGeAlD
Sorafenib—PDGFRB—spinal cord—Creutzfeldt-Jakob disease	0.00376	0.00436	CbGeAlD
Sorafenib—RET—brain—Creutzfeldt-Jakob disease	0.00376	0.00436	CbGeAlD
Sorafenib—EPHX2—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00365	0.0265	CbGpPWpGaD
Sorafenib—MAP2K5—central nervous system—Creutzfeldt-Jakob disease	0.00352	0.00409	CbGeAlD
Sorafenib—KDR—central nervous system—Creutzfeldt-Jakob disease	0.00352	0.00409	CbGeAlD
Sorafenib—RALBP1—brain—Creutzfeldt-Jakob disease	0.00348	0.00404	CbGeAlD
Sorafenib—MAP2K5—cerebellum—Creutzfeldt-Jakob disease	0.00344	0.004	CbGeAlD
Sorafenib—KDR—cerebellum—Creutzfeldt-Jakob disease	0.00344	0.004	CbGeAlD
Sorafenib—CSF1R—central nervous system—Creutzfeldt-Jakob disease	0.00344	0.00399	CbGeAlD
Sorafenib—CSF1R—cerebellum—Creutzfeldt-Jakob disease	0.00336	0.0039	CbGeAlD
Sorafenib—FLT1—brain—Creutzfeldt-Jakob disease	0.00331	0.00384	CbGeAlD
Sorafenib—RAF1—brain—Creutzfeldt-Jakob disease	0.00329	0.00382	CbGeAlD
Sorafenib—EPHB6—brain—Creutzfeldt-Jakob disease	0.00327	0.00379	CbGeAlD
Sorafenib—HTR2C—spinal cord—Creutzfeldt-Jakob disease	0.00317	0.00368	CbGeAlD
Sorafenib—STK10—brain—Creutzfeldt-Jakob disease	0.00313	0.00363	CbGeAlD
Sorafenib—KIT—central nervous system—Creutzfeldt-Jakob disease	0.00312	0.00362	CbGeAlD
Sorafenib—RAF1—p38 signaling mediated by MAPKAP kinases—YWHAZ—Creutzfeldt-Jakob disease	0.00311	0.0225	CbGpPWpGaD
Sorafenib—PDGFRA—brain—Creutzfeldt-Jakob disease	0.0031	0.0036	CbGeAlD
Sorafenib—KIT—cerebellum—Creutzfeldt-Jakob disease	0.00305	0.00354	CbGeAlD
Sorafenib—PDGFRB—central nervous system—Creutzfeldt-Jakob disease	0.00305	0.00354	CbGeAlD
Sorafenib—PDGFRB—cerebellum—Creutzfeldt-Jakob disease	0.00298	0.00346	CbGeAlD
Sorafenib—ABCB1—blood plasma—Creutzfeldt-Jakob disease	0.00295	0.00342	CbGeAlD
Sorafenib—FGFR1—NCAM signaling for neurite out-growth—PRNP—Creutzfeldt-Jakob disease	0.00291	0.021	CbGpPWpGaD
Sorafenib—KDR—brain—Creutzfeldt-Jakob disease	0.0028	0.00325	CbGeAlD
Sorafenib—MAP2K5—brain—Creutzfeldt-Jakob disease	0.0028	0.00325	CbGeAlD
Sorafenib—CSF1R—brain—Creutzfeldt-Jakob disease	0.00273	0.00317	CbGeAlD
Sorafenib—MAP3K7—Downstream TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00269	0.0195	CbGpPWpGaD
Sorafenib—HTR2C—central nervous system—Creutzfeldt-Jakob disease	0.00257	0.00298	CbGeAlD
Sorafenib—RAF1—Ceramide signaling pathway—CTSD—Creutzfeldt-Jakob disease	0.00253	0.0183	CbGpPWpGaD
Sorafenib—KIT—brain—Creutzfeldt-Jakob disease	0.00248	0.00288	CbGeAlD
Sorafenib—ABCC4—central nervous system—Creutzfeldt-Jakob disease	0.00243	0.00282	CbGeAlD
Sorafenib—PDGFRB—brain—Creutzfeldt-Jakob disease	0.00242	0.00281	CbGeAlD
Sorafenib—HTR2B—central nervous system—Creutzfeldt-Jakob disease	0.00242	0.0028	CbGeAlD
Sorafenib—RAF1—IGF1 pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00233	0.0169	CbGpPWpGaD
Sorafenib—CYP2D6—brainstem—Creutzfeldt-Jakob disease	0.00233	0.0027	CbGeAlD
Sorafenib—RAF1—NCAM signaling for neurite out-growth—PRNP—Creutzfeldt-Jakob disease	0.00233	0.0169	CbGpPWpGaD
Sorafenib—UGT1A9—PPARA activates gene expression—NPAS2—Creutzfeldt-Jakob disease	0.00223	0.0161	CbGpPWpGaD
Sorafenib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NPAS2—Creutzfeldt-Jakob disease	0.00218	0.0158	CbGpPWpGaD
Sorafenib—CYP2B6—lymphoid tissue—Creutzfeldt-Jakob disease	0.00215	0.00249	CbGeAlD
Sorafenib—ABCG2—spinal cord—Creutzfeldt-Jakob disease	0.00211	0.00245	CbGeAlD
Sorafenib—RAF1—Class I PI3K signaling events mediated by Akt—YWHAZ—Creutzfeldt-Jakob disease	0.00206	0.0149	CbGpPWpGaD
Sorafenib—HTR2C—brain—Creutzfeldt-Jakob disease	0.00204	0.00237	CbGeAlD
Sorafenib—EPHX2—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.00202	0.0146	CbGpPWpGaD
Sorafenib—MAP3K7—TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00201	0.0146	CbGpPWpGaD
Sorafenib—RET—SIDS Susceptibility Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00198	0.0144	CbGpPWpGaD
Sorafenib—RAF1—GMCSF-mediated signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.00197	0.0143	CbGpPWpGaD
Sorafenib—ABCC4—brain—Creutzfeldt-Jakob disease	0.00193	0.00224	CbGeAlD
Sorafenib—HTR2B—brain—Creutzfeldt-Jakob disease	0.00192	0.00222	CbGeAlD
Sorafenib—EPHB6—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00186	0.0134	CbGpPWpGaD
Sorafenib—BRAF—mTOR signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.0018	0.013	CbGpPWpGaD
Sorafenib—EPHA6—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00174	0.0126	CbGpPWpGaD
Sorafenib—ABCG2—cerebellum—Creutzfeldt-Jakob disease	0.00168	0.00194	CbGeAlD
Sorafenib—EPHX2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00163	0.0118	CbGpPWpGaD
Sorafenib—CYP2B6—central nervous system—Creutzfeldt-Jakob disease	0.00158	0.00183	CbGeAlD
Sorafenib—PDGFRA—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.00151	0.0109	CbGpPWpGaD
Sorafenib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NPAS2—Creutzfeldt-Jakob disease	0.0015	0.0109	CbGpPWpGaD
Sorafenib—MAP2K5—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00149	0.0108	CbGpPWpGaD
Sorafenib—MAPK11—Regulation of mRNA stability by proteins that bind AU-rich elements—YWHAZ—Creutzfeldt-Jakob disease	0.00147	0.0106	CbGpPWpGaD
Sorafenib—CYP2C8—brain—Creutzfeldt-Jakob disease	0.0014	0.00162	CbGeAlD
Sorafenib—ABCG2—brain—Creutzfeldt-Jakob disease	0.00136	0.00158	CbGeAlD
Sorafenib—EPHB6—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00132	0.00958	CbGpPWpGaD
Sorafenib—CYP2B6—brain—Creutzfeldt-Jakob disease	0.00126	0.00146	CbGeAlD
Sorafenib—EPHA6—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00124	0.00901	CbGpPWpGaD
Sorafenib—RAF1—mTOR signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00124	0.00899	CbGpPWpGaD
Sorafenib—BRAF—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00124	0.00897	CbGpPWpGaD
Sorafenib—CYP3A4—central nervous system—Creutzfeldt-Jakob disease	0.00119	0.00139	CbGeAlD
Sorafenib—CYP2D6—central nervous system—Creutzfeldt-Jakob disease	0.00117	0.00136	CbGeAlD
Sorafenib—ABCB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00115	0.00133	CbGeAlD
Sorafenib—CYP2D6—cerebellum—Creutzfeldt-Jakob disease	0.00115	0.00133	CbGeAlD
Sorafenib—KDR—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00113	0.0082	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.0011	0.00798	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—CTSD—Creutzfeldt-Jakob disease	0.0011	0.00796	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00108	0.00783	CbGpPWpGaD
Sorafenib—BRAF—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00108	0.0078	CbGpPWpGaD
Sorafenib—ABCB1—spinal cord—Creutzfeldt-Jakob disease	0.00104	0.00121	CbGeAlD
Sorafenib—CYP2D6—brain—Creutzfeldt-Jakob disease	0.000933	0.00108	CbGeAlD
Sorafenib—EPHX2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.0009	0.00651	CbGpPWpGaD
Sorafenib—RAF1—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.000857	0.0062	CbGpPWpGaD
Sorafenib—ABCB1—central nervous system—Creutzfeldt-Jakob disease	0.000845	0.000981	CbGeAlD
Sorafenib—RAF1—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.000838	0.00607	CbGpPWpGaD
Sorafenib—PDGFRB—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000836	0.00605	CbGpPWpGaD
Sorafenib—FGFR1—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000834	0.00604	CbGpPWpGaD
Sorafenib—ABCB1—cerebellum—Creutzfeldt-Jakob disease	0.000826	0.000958	CbGeAlD
Sorafenib—KDR—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000809	0.00585	CbGpPWpGaD
Sorafenib—RAF1—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000745	0.0054	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000695	0.00503	CbGpPWpGaD
Sorafenib—MAPK11—Metabolism of mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.000694	0.00503	CbGpPWpGaD
Sorafenib—ABCB1—brain—Creutzfeldt-Jakob disease	0.000671	0.000779	CbGeAlD
Sorafenib—RAF1—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000668	0.00483	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000598	0.00433	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000595	0.00431	CbGpPWpGaD
Sorafenib—MAPK11—Metabolism of RNA—YWHAZ—Creutzfeldt-Jakob disease	0.000594	0.0043	CbGpPWpGaD
Sorafenib—MAP3K7—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000579	0.00419	CbGpPWpGaD
Sorafenib—ABCB1—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.000572	0.00414	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000569	0.00412	CbGpPWpGaD
Sorafenib—ABCC4—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000562	0.00407	CbGpPWpGaD
Sorafenib—MAP3K7—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000514	0.00372	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000508	0.00368	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000482	0.00349	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000482	0.00349	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000477	0.00345	CbGpPWpGaD
Sorafenib—RAF1—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000473	0.00342	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling by Wnt—YWHAZ—Creutzfeldt-Jakob disease	0.000466	0.00337	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000463	0.00335	CbGpPWpGaD
Sorafenib—RAF1—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.00044	0.00319	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000438	0.00317	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000438	0.00317	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000416	0.00301	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000415	0.003	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000409	0.00296	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000405	0.00293	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000396	0.00287	CbGpPWpGaD
Sorafenib—RAF1—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000391	0.00283	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000373	0.0027	CbGpPWpGaD
Sorafenib—MKNK1—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000334	0.00242	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000333	0.00241	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000315	0.00228	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000312	0.00226	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000312	0.00226	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000299	0.00217	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000296	0.00214	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000295	0.00214	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000295	0.00213	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000293	0.00212	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.00029	0.0021	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000287	0.00208	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000282	0.00204	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000281	0.00203	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000277	0.00201	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000277	0.00201	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000266	0.00193	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000266	0.00193	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000266	0.00193	CbGpPWpGaD
Sorafenib—KIT—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000266	0.00192	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000266	0.00192	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000263	0.0019	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000262	0.0019	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000256	0.00185	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000254	0.00184	CbGpPWpGaD
Sorafenib—CDK7—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.000253	0.00183	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000252	0.00182	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000251	0.00182	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000244	0.00176	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000237	0.00172	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000236	0.00171	CbGpPWpGaD
Sorafenib—CDK7—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000235	0.0017	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000234	0.00169	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000226	0.00164	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000226	0.00164	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000226	0.00164	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000224	0.00162	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000221	0.0016	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000219	0.00158	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000211	0.00152	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000211	0.00152	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00021	0.00152	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000208	0.00151	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000206	0.00149	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000202	0.00146	CbGpPWpGaD
Sorafenib—KIT—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000189	0.00137	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000189	0.00137	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000186	0.00135	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.000185	0.00134	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00018	0.0013	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000179	0.0013	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000176	0.00128	CbGpPWpGaD
Sorafenib—BRAF—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.00017	0.00123	CbGpPWpGaD
Sorafenib—KIT—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000168	0.00122	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000168	0.00122	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000166	0.0012	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000162	0.00117	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000161	0.00117	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000159	0.00115	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000159	0.00115	CbGpPWpGaD
Sorafenib—KIT—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000155	0.00112	CbGpPWpGaD
Sorafenib—FGFR1—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000147	0.00107	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000147	0.00106	CbGpPWpGaD
Sorafenib—RAF1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000144	0.00104	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000144	0.00104	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000143	0.00104	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00014	0.00101	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00014	0.00101	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000136	0.000985	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000132	0.000958	CbGpPWpGaD
Sorafenib—RAF1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000128	0.000925	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000125	0.000906	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000122	0.000884	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00012	0.000872	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000119	0.000864	CbGpPWpGaD
Sorafenib—RAF1—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000118	0.000854	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000115	0.000833	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000114	0.000826	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000109	0.000786	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000109	0.000786	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000103	0.000746	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000103	0.000744	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	9.75e-05	0.000706	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	9.26e-05	0.000671	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	8.84e-05	0.00064	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	8.26e-05	0.000598	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—NPAS2—Creutzfeldt-Jakob disease	7.52e-05	0.000545	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	7.13e-05	0.000516	CbGpPWpGaD
